UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in RCUS — Arcus Biosciences, Inc.
CIK 861177
NEW YORK, NY
Position in RCUS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,419,103
-$14,627 QoQ
Shares Held
158,292
+9.9% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 46.010537487681.ToString("F0")%
Shared 0.ToString("F0")%
None 53.98946251231901.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. RCUS ranks #87 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in RCUS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,419,103 | 158,292 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,433,730 | 144,093 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,193,682 | 87,771 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,413,084 | 173,598 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $764,768 | 97,423 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $923,387 | 62,014 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,068,556 | 69,886 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,475,052 | 96,852 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,137,827 | 378,063 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,614,518 | 398,666 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,288,541 | 406,047 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,353,500 | 411,300 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,502,109 | 411,300 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,308,580 | 401,769 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,686,559 | 446,734 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,417,061 | 450,555 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,904,724 | 313,838 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,761,806 | 241,211 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,449,789 | 41,577 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,016,568 | 37,020 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $937,478 | 33,386 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $979,080 | 37,715 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $390,792 | 22,800 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $762,362 | 30,815 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||